MedPath

Effect of combined magnesium and vitamin E supplementation in treatment of diabetic foot ulcer

Phase 2
Conditions
Diabetic foot ulcer.
Non-insulin-dependent diabetes mellitus and with peripheral circulatory complications
E14.5
Registration Number
IRCT2017090533941N21
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with grade 3 diabetic foot ulcer
Aged 40 to 85

Exclusion Criteria

Pregnant and breastfed patients
Participants who consumed magnesium, vitamin E or other antioxidative supplements during past 3 months
Taking anti-inflammatory agents
Change in consuming medications throughout the study
Patients with history of diseases which influence the development of diabetic foot ulcer including chronic trauma

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation using HOMA formula.;Healing of diabetic foot ulcer. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Decrease of the wound size relative to original size: ulcer length (cm), ulcer width (cm), Ulcer depth (cm).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath